Navigation Links
Mast Therapeutics Reports Third Quarter 2013 Financial Results
Date:11/4/2013

SAN DIEGO, Nov. 4, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported financial results for the quarter ended September 30, 2013.

Brian M. Culley, Chief Executive Officer, said: "We continue to focus on EPIC, our pivotal phase 3 study of MST-188 in sickle cell disease.  We almost doubled the number of open clinical sites since the end of the second quarter and are approaching our goal of opening 40 clinical sites in the U.S. Beginning next year, we also plan to open approximately 30 clinical sites outside the U.S."

Mr. Culley continued: "In addition to sickle cell disease, we are evaluating MST-188 in other areas of significant unmet medical need and plan to initiate a 60-patient phase 2 study in acute limb ischemia in early 2014.  This study will determine whether MST-188 improves the effectiveness of existing thrombolytic agents, such as Activase®, a tissue plasminogen activator (tPA) that is approved to treat stroke, heart attack and pulmonary embolism.  If our phase 2 study demonstrates that MST-188 improves the 'clot busting' activity of tPA, we believe it will open the door to developing MST-188 in combination with tPA in all settings in which thrombolytics are used, most notably stroke." 

Third Quarter 2013 Operating ResultsThe Company's net loss for the third quarter of 2013 was $5.3 million, or $0.05 per share (basic and diluted), compared to a net loss of $3.2 million, or $0.07 per share (basic and diluted), for the same period in 2012.

Research and development (R&D) expenses for the third quarter of 2013 were $3.1 million, an increase of $1.4 million, or 87%, compared to $1.7 million for the same period in 2012. The increase was primarily due to increases of $1.3 million in external clinical study fees and expenses and $
'/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients
2. Echo Therapeutics Schedules Third Quarter 2013 Financial Results for Thursday, November 7, 2013
3. G1 Therapeutics to Present at Southeast BIO Investor & Partnering Forum
4. Cell Therapeutics Reports Third Quarter 2013 Financial Results
5. Sorrento Therapeutics Announces Closing of Public Offering of Common Stock
6. Abide Therapeutics Appoints Dr. Gary ONeill as Vice President of Biology
7. Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013
8. Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure
9. Sorrento Therapeutics Announces Pricing of Public Offering of 4,150,000 Shares of Common Stock and Listing on NASDAQ
10. ISSYS Inc. will showcase its Titan Wireless Implantable Hemodynamic Monitor and its clinical study summary at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference (Booth 1638) in San Francisco (October 29 to 31, 2013)
11. Aratana Therapeutics Adds to Commercial Leadership Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015   Regulus Therapeutics Inc . ( NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... quarter ended June 30, 2015 on Tuesday, August 4, ... Regulus will host a conference call and webcast ... Daylight Time to discuss its second quarter 2015 financial ...
(Date:7/28/2015)... July 28, 2015  Psychemedics Corporation (NASDAQ: PMD ... period ended June 30, 2015.  The Company also announced ... shareholders of record as of August 7, 2015 to ... the Company,s 76 th consecutive quarterly dividend. ... 30, 2015 was $7.0 million versus $7.7 million for ...
(Date:7/28/2015)... 28, 2015 Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ... Medical Equipment Market - Global Forecasts to 2019" ... medical equipment market is estimated to grow expected to ... 12.5% from 2014 to 2019. ... due to financial constraints, increasing privatization in the healthcare ...
Breaking Medicine Technology:Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Psychemedics Corporation Announces Second Quarter Earnings 2Psychemedics Corporation Announces Second Quarter Earnings 3Psychemedics Corporation Announces Second Quarter Earnings 4Psychemedics Corporation Announces Second Quarter Earnings 5Psychemedics Corporation Announces Second Quarter Earnings 6Psychemedics Corporation Announces Second Quarter Earnings 7Psychemedics Corporation Announces Second Quarter Earnings 8Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2
... 2010 Reportlinker.com announces that a new market ... Women,s Health Diagnostic Testing ... of this TriMark Publications report is to describe ... (IVDs) market called women,s health testing. This study ...
... YORK, Dec. 29, 2010 Reportlinker.com announces that ... its catalogue: The Outlook for ... http://www.reportlinker.com/p0203102/The-Outlook-for-Pharmaceuticals-in-Central-Asia.html The Outlook for Pharmaceutical ... management reports from Espicom Business Intelligence. Each report ...
Cached Medicine Technology:Reportlinker Adds Women's Health Diagnostic Testing 2Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia 2Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia 3
(Date:7/29/2015)... , ... July 29, 2015 , ... Wedding season is in full swing, which means ... extra pressure of looking good on the big day. Every bride wants to look and ... new level. , According to a recent study by the American ...
(Date:7/29/2015)... ... ... We are privileged to announce that U.S. News & World Report has ranked ... in the nation for 2015-2016. This marks the 21st consecutive year that the USC Eye ... an honor to be included in the top 10 ophthalmology hospitals by U.S. News & ...
(Date:7/29/2015)... ... 29, 2015 , ... CanAm Enterprises, LLC (“CanAm”) is thrilled to announce that ... approvals have been granted to investors in four different CanAm EB-5 projects -- the ... in Philadelphia, and the Valley Forge Convention Center project in CanAm’s regional center in ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... of American Farmer, airing fall of 2015 on RFD-TV. , Fastline is dedicated ... will learn about Fastline.com, which contains the largest and freshest searchable agriculture equipment ...
(Date:7/29/2015)... ... ... Awareness Month, and in honor of this month, Dr. Melda Isaac of MI-Skin Dermatology and ... as well as how to best treat existing sun damage. Sun damage can range from ... America. Many people do not protect their skin sufficiently when going out in the sun, ...
Breaking Medicine News(10 mins):Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3
... (June 10, 2008) The Endocrine Society ... investigator at Los Angeles Biomedical Research Institute at ... Educator Award during its annual convention June 15-18 ... international association of 13,000 members representing the full ...
... 2008) Screening for lung cancer with computed tomography (CT) ... smokers, but it won,t protect them from other causes of ... in the July issue of the journal Radiology . ... way to reduce risk of death from lung cancer," said ...
... Middle- and upper-income families find it harder to get needed ... -- The number of American adults who had inadequate health ... 2003 to 2007, from 16 million to more than 25 ... higher incomes, those whose income was 200 percent above the ...
... That Include,Avastin, Erbitux, Rituxan/MabThera, According to a New Report from Decision ... ... Mass., June 10 Decision Resources, one of the,world,s leading research ... antibodies (MAbs) drug market,will more than double to $16.7 billion in ...
... SCOTTSDALE, Ariz., June 10 Examination Management,Services, ... retrieval services,in the nation, and Cybersettle, the ... to provide Cybersettle users with integrated,medical record ... of,claim disputes., Combining Cybersettle,s Web-based dispute ...
... Announce Plans for Celebrating World Blood Donor,Day on ... To increase national,and global appreciation of volunteer blood ... (ADRP) are partnering together to,encourage their respective members ... 14. This specific day marks the birthday of ...
Cached Medicine News:Health News:LA BioMed investigator wins Distinguished Educator Award 2Health News:CT lung cancer screening no cure-all for smokers 2Health News:25 Million Americans Are 'Underinsured' 2Health News:25 Million Americans Are 'Underinsured' 3Health News:25 Million Americans Are 'Underinsured' 4Health News:The Monoclonal Antibodies Drug Market for the Treatment of Cancer Will More Than Double to $16.7 Billion By 2016 2Health News:EMSI and Cybersettle Partner to Provide Cybersettle Clients With Medical Record Retrieval Services 2Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 2Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 3Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 4
... is a precise, reliable and technologically ... been designed for OEM production. Its ... according to the method bottles size., ... to process automatically the whole ELISA ...
The GEM OPL CO-Oximeter provides comprehensive oxygenation status in an easy-to-use, portable manner. The GEM OPL is the ideal solution for laboratory or point-of-care CO-Oximetry testing....
The Maxi-Therm® lite hyper-hypothermia water blankets from Cincinnati Sub-Zero take conductive warming and cooling therapy to a new, softer level. These blankets are soft, lightweight, and remai...
The ImmunoWELL Mycoplasma Pneumoniae Antibody (IgM) Test is a qualitative enzyme immunoassay (EIA) for the detection of specific IgM antibodies to M. pneumoniae in serum and is an aid in the diagnosi...
Medicine Products: